Pyridostigmine Bromide
Pyridostigmine bromide is the bromide salt form of pyridostigmine, a reversible cholinesterase inhibitor used for the symptomatic treatment of myasthenia gravis and as a prophylactic agent against organophosphate nerve agent poisoning. See pyridostigmine for complete pharmacological details.
Peso molecular
261,1200 g/mol
TPSA
33,40 Ų
Áreas terapéuticas
Mecanismo de acción
Inhibits acetylcholinesterase, the enzyme that hydrolyzes acetylcholine in the synaptic cleft. This increases acetylcholine availability at cholinergic synapses, enhancing cholinergic neurotransmission.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Inhibits acetylcholinesterase, the enzyme that hydrolyzes acetylcholine in the synaptic cleft. This increases acetylcholine availability at cholinergic synapses, enhancing cholinergic neurotransmission.
Estructura 2D
Cite this structure
Embed this structure
SMILES
CN(C)C(=O)Oc1ccc[n+](C)c1.[Br-]
InChI
InChI=1S/C9H13N2O2.BrH/c1-10(2)9(12)13-8-5-4-6-11(3)7-8;/h4-7H,1-3H3;1H/q+1;/p-1
Molecular Formula
C9H13BrN2O2
HBD / HBA
- / 3
Enlaces Rotables
2
Átomos Pesados
14
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Preguntas frecuentes
Pyridostigmine bromide is the bromide salt form of pyridostigmine, a reversible cholinesterase inhibitor used for the symptomatic treatment of myasthenia gravis and as a prophylactic agent against organophosphate nerve agent poisoning. See pyridostigmine for complete pharmacological details.
Inhibits acetylcholinesterase, the enzyme that hydrolyzes acetylcholine in the synaptic cleft. This increases acetylcholine availability at cholinergic synapses, enhancing cholinergic neurotransmission.
Yes, Pyridostigmine Bromide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL812. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 7550. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="pyridostigmine-bromide"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/pyridostigmine-bromide/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/pyridostigmine-bromide/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/pyridostigmine-bromide/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="pyridostigmine-bromide"></drugfyi-drug>